Ji Young Jeon

Title: Ji Young Jeon: Innovator in Pharmaceutical Chemistry

Introduction

Ji Young Jeon is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds aimed at combating cancer. With a total of six patents to his name, his work has garnered attention for its potential therapeutic applications.

Latest Patents

Among Ji Young Jeon's latest patents is a sulfonamide derivative with a fused pyrimidine skeleton, which exhibits an epidermal growth factor receptor mutation inhibitory effect. This innovative compound is represented by a specific formula and includes a pharmaceutical composition that utilizes it as an active ingredient. The derivative has shown effectiveness in suppressing the growth of cancer cells and overcoming drug resistance caused by mutations in the tyrosine kinase domain of epidermal growth factor receptors. Another notable patent involves the crystal form of an acid addition salt of a furopyrimidine compound, which provides crystalline forms that can be easily utilized in pharmaceutical compositions.

Career Highlights

Ji Young Jeon has worked with reputable companies in the pharmaceutical industry, including Hanmi Science Co., Ltd. and Hanmi Pharm. Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Ji Young Jeon has collaborated with talented individuals such as Tae Hee Ha and Eun Joo Kwak, who have contributed to his research and development efforts.

Conclusion

Ji Young Jeon's innovative work in pharmaceutical chemistry, particularly in developing compounds for cancer treatment, highlights his significant contributions to the field. His patents reflect a commitment to advancing medical science and improving patient outcomes.